Prognostic Value Of Fetal Urinary Beta-2 Microglobuline In Vesicoamniotic Shunting Therapy For Fetal Obstructive Uropathy
##plugins.themes.bootstrap3.article.main##
Abstract
Introduction and objectives. Fetal obstructive uropathy can be treated early in pregnancy by intrauterine vesicoamniotic
shunting, immediately after being diagnosed by ultrasound, in specific cases with a favorable prognosis in renal function using
fetal urinary beta-2 microglobuline. The main objective of the study was to determine the changes of beta-2 microglobuline
in consecutive samples of fetal urine in 48 – 72 hour-intervals in fetuses with obstructive uropathy at 16 weeks of gestation.
Methods. We performed a descriptive and longitudinal study, including 15 pregnant women whose fetuses were diagnosed
with obstructive uropathy and without chromosomal abnormalities, performing vesicocentesis for urinary biometry.
Downloads
##plugins.themes.bootstrap3.article.details##
Section
Originals articles
How to Cite
Gil-Guevara, E. D., Diaz, R., & Bermudez, C. (2017). Prognostic Value Of Fetal Urinary Beta-2 Microglobuline In Vesicoamniotic Shunting Therapy For Fetal Obstructive Uropathy. Revista Peruana De Investigación Materno Perinatal, 6(1), 9–16. https://doi.org/10.33421/inmp.201771